Advertisement

Ads Placeholder
Loading...

Beam Therapeutics Inc.

BEAM•NASDAQ
Healthcare
Biotechnology
$24.66
$0.44(1.82%)
U.S. Market opens in 45h 37m

Beam Therapeutics Inc. (BEAM) Stock Overview

Explore Beam Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.5B
P/E Ratio-31.72
EPS (TTM)$-0.81
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$17.88
3 Months$20.04
1 Year Target$22.34

BEAM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Beam Therapeutics Inc. (BEAM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.72 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.82%
5-Day Change
5.12%
1-Month Change
-9.40%
3-Month Change
-9.14%
6-Month Change
-4.23%
Year-to-Date (YTD) Change
-9.14%
1-Year Change
49.82%
3-Year Change
-18.15%
5-Year Change
-69.40%
All-Time (Max) Change
31.52%

Contact Information

https://www.beamtx.com
857 327 8775
238 Main Street, Cambridge, MA, 02142

Company Facts

3,930 Employees
IPO DateFeb 6, 2020
CountryUS
Actively Trading

Frequently Asked Questions